TCM
ACRS icon

TCG Crossover Management’s Aclaris Therapeutics ACRS Stock Holding History

TCG Crossover Management’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-529,839
Closed -$5.49M – 27
2023
Q2 		$5.49M Hold
529,839
– – 0.9% 20
2023
Q1 		$4.29M Sell
529,839
-615,100
-54% -$7.81M 0.84% 19
2022
Q4 		$18M Hold
1,144,939
– – 3.18% 12
2022
Q3 		$18M Hold
1,144,939
– – 5.41% 8
2022
Q2 		$16M Hold
1,144,939
– – 6.79% 6
2022
Q1 		$19.7M Buy
1,144,939
+62,726
+6% +$856K 7.92% 4
2021
Q4 		$15.7M Buy
+1,082,213
New +$16.4M 7.37% 6

Other funds holding ACRS

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return